Trend in approval of targeted biologics in the last two decades
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
Autore principale: | Siddika, Khadiza |
---|---|
Altri autori: | Ahmed, Syeda Maliha |
Natura: | Tesi |
Lingua: | English |
Pubblicazione: |
Brac University
2024
|
Soggetti: | |
Accesso online: | http://hdl.handle.net/10361/24296 |
Documenti analoghi
-
Targeted therapeutic options in the treatment of Breast Cancer
di: Alam, Kazi Tasnuva
Pubblicazione: (2022) -
Study on anticancer drugs approved by the FDA from 2014 to 2023
di: Rattry, Faria Rahman
Pubblicazione: (2024) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
di: Tania, Umme
Pubblicazione: (2023) -
RIPK pathway, as a potential target, for cancer treatment - a review
di: Jahan, Nusrat
Pubblicazione: (2024) -
Molecular biology : genes to proteins /
di: Tropp, Burton E.
Pubblicazione: (2008)